Revenue

Manas AI gains unique access to Schrödinger's physics platform, uniting top minds and tech to slash drug development timelines. Is this the future?

Inogen reports modest growth and a pivotal return to positive EBITDA, yet a revenue miss from delayed B2B orders raises questions for its turnaround.

With $6.5M CAD in new funding, Montréal's AI4Eyes is set to accelerate the global launch of its all-in-one diagnostic and treatment platform.

Miro launches AI Workflows, aiming to transform team collaboration by making AI a visual partner on its canvas, promising to slash project times.

Progyny signals better-than-expected 2025 results on robust member engagement, sparking analyst upgrades and sending its stock soaring ahead of a key conference.

The fintech firm completes its transformation into a diversified industrial compounder, creating GPGI Inc. under the leadership of veteran CEO Dave Cote.

New 2025 data reveals an AI platform is slashing costs, improving chronic disease outcomes, and closing health equity gaps for hundreds of clinicians.

Kyle Addington of American Wealth Advisers joins IFG's new advisory council, giving local clients a voice in the future of financial services nationwide.

As McGraw Hill execs prep for a key investor conference, all eyes are on their digital-first strategy and how they'll navigate the AI-driven EdTech boom.

With a new board member and strategic investment, Kandu, Inc. is set to scale its brain-computer interface technology for stroke recovery.

MediKarma is licensing autonomous AI agents to manage disease and data, aiming to become the core processor for the entire healthcare industry.

VisionWave Holdings launches a major joint venture with Israeli partner AIPHEX, integrating AI, quantum tech, and a key financial contract.

The wellness firm secured a cash infusion by repricing options, a move that provides vital funds for its Zola brand but raises questions about dilution.

The legendary Southern chicken chain has landed in Brooklyn with a 24-hour drive-thru, testing its iconic flavors in NYC's competitive food scene.

Offerpad raises $18M in a direct offering. The move aims to bolster its finances and fund a strategic pivot to asset-light services in a changing market.

Carlsmed's AI-driven aprevo® platform shows massive surgeon adoption and market growth, signaling a new era of personalized, cost-effective spine care.

The Nashville hot chicken giant appoints a new franchise VP to manage its explosive growth, targeting Europe, Asia, and non-traditional US locations.

Petco is refinancing $1.5B in debt to extend maturities while reaffirming its financial outlook. Is this a sign of strength or underlying strain?

Following a successful three-year transformation, B-FLEXION acquires full ownership of Radius Health, betting big on its blockbuster osteoporosis drug TYMLOS®.

The supply chain tech leader appoints a seasoned marketing exec from Drift and Salesforce to accelerate its next growth phase and amplify its AI strategy.